165 results
Page 6 of 9
6-K
EX-1.1
04evcgt5 r7
7 Mar 14
BioLineRx Closes $24.1 Million Underwritten Public Offering
12:00am
424B5
wng7geqawfeu6j
4 Mar 14
Prospectus supplement for primary offering
12:00am
424B5
847vgyha
3 Mar 14
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
gdimg 40o8
3 Mar 14
Current report (foreign)
12:00am
6-K
EX-99
xj096m qjyt1ukni1v
23 Jan 14
BioLineRx Receives Orphan Drug
12:00am
6-K
EX-99
5mdc mrbhfnymzc3vw
9 Sep 13
BioLineRx’s BL-8040 Receives Orphan Drug
12:00am
424B3
vkm16ul648
8 Aug 13
Prospectus supplement
12:00am
6-K
EX-99
076bx 0auss60lj
6 Aug 13
BioLineRx Reports Second Quarter 2013 Results
12:00am
424B5
56lzge6j 7hkejr
17 May 13
Prospectus supplement for primary offering
12:00am
424B5
998g6k gwkiqnx
17 May 13
Prospectus supplement for primary offering
12:00am
6-K
EX-10.1
wsfn68g6zp1vktya2nfz
17 May 13
BioLineRx Enters into “At-The-Market” Offering
12:00am
6-K
EX-99
e4ub 1ovf
7 May 13
BioLineRx Reports First Quarter 2013 Results
12:00am
424B5
y9l3pooaalunqh34x1d
6 Feb 13
Prospectus supplement for primary offering
12:00am
6-K
EX-99
dmq2ov3f j1vrev209
16 Oct 12
Current report (foreign)
12:00am
424B3
xk29ngovc9c7z
15 Oct 12
Prospectus supplement
12:00am
F-1
u93a wngm6fx3ulzyfb
2 Oct 12
Registration statement (foreign)
12:00am
6-K
EX-99
vn1b3z
27 Sep 12
Current report (foreign)
12:00am
6-K
EX-99
jv31dw7ugy twovx
15 Aug 12
BioLineRx Reports Second Quarter 2012 Results
12:00am
F-3/A
EX-4.2
s68xf
13 Aug 12
Shelf registration (foreign) (amended)
12:00am